Venture financing of French biotech companies is setting out to be very strong in the second half of this year, as it has already surpassed the levels seen in the second half of 2013 and 2014 respectively. France LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify … Continue reading French Life Sciences Trend Analysis 2015
Category: Life Sciences Reports
This area includes the yearly life sciences and Biotech reports with statistics retrieved from Biotechgate.
Life Science Trend Analysis 2015 for Italy
Venture financing of Italian biotech companies is picking up once again. In the first half of 2015 alone, USD 17.8M was raised, which is making it the second best half in 5 years. Life science venture financing was somewhat disappointing in 2014 compared to 2013 where USD 8.15M and USD 20.38M was raised respectively. Click … Continue reading Life Science Trend Analysis 2015 for Italy
Life Science Trend Analysis 2015 for Austria
With three rounds of financing and a combined value of USD 6.7M, 2014 proved to be a weak year for biotech financing in Austria. 2015 is set to look very different, as Austrian biotech financing gains momentum with an impressive USD 50M financing round to Nabriva to start off the first half of 2015. Click … Continue reading Life Science Trend Analysis 2015 for Austria
Dutch Life Sciences Trend Analysis 2015
3 Dutch companies, ProQR, UniQure and arGEN-X went public and raised approximately USD 272.5M combined. Nonetheless, the Biotech industry in the Netherlands has faced a drop in financing value of more than 50% whilst the number of rounds has decreased by 21%. The number of Biotech companies in the Netherlands has however increased significantly, from … Continue reading Dutch Life Sciences Trend Analysis 2015
Spanish Life Sciences Trend Analysis 2015
The biotechnology venture sector faced over a 90% decrease in its financing value and a drop of 80% in financing rounds. Over the last three years the remarkable decrease in investments was continuing in 2014. But for the first half of 2015 (until May 2015) the number of investments in biotech ventures has increased by … Continue reading Spanish Life Sciences Trend Analysis 2015
Swiss Life Sciences Trend Analysis 2015
In comparison to the previous year, the amount of financing for the life science companies decreased by almost 37% in 2014. In contrast to this, the amount of products in development increased in the first half of 2015 which indicates a continuous growth of the industry. Click here to download Swiss Life Sciences Trend Analysis … Continue reading Swiss Life Sciences Trend Analysis 2015
South Korean Life Sciences Trend Analysis 2015
South Korea has become an important player in the Biotech and Life Sciences space. Click here to download South Korean Life Sciences Trend Analysis 2013 – 11 pages Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
UK Life Sciences Trend Analysis 2014
2013 closed with the total venture financing value raised by Biotech companies in the U.K. being decreased by 47% compared to its 2012 level (USD 283m in 2013 compared to USD 530m in 2012). The number of U.K. biotech products (therapeutics and diagnostics) in the first stage of the clinical pipeline (Phase I) was increased … Continue reading UK Life Sciences Trend Analysis 2014
Canadian Life Sciences Trend Analysis 2014
In 2013 the venture capital raised by Biotechnology companies in Canada almost doubled (93% increase) compared to the previous year’s figure, to reach a total of USD 139m. The majority of Biotech products in the industry belong to the area of oncology, followed by products developed for nervous system and for Infectious diseases indications. Distributors, … Continue reading Canadian Life Sciences Trend Analysis 2014
Danish Life Sciences Trend Analysis 2014
In 2013, the total venture financing value amassed by Danish Biotechnology companies was by 64% increased compared to the previous year’s figure (USD 82m in 2013 compared to USD 50m in 2012). This summer’s snapshot of the Danish biotech industry reveals that 1 in 10 biotech companies are publicly traded; a 4 percentage point increase … Continue reading Danish Life Sciences Trend Analysis 2014